Delphine Bernard is Research Director at MedDay. After a PhD in non-coding RNA in synaptogenesis at the Ecole Normale Supérieure (Paris), Delphine worked as a Researcher in a biotechnology company called Hera Diagnostics, which specialised in the development of non-invasive prenatal diagnosis techniques. She gained experience in molecular and cellular biology as well as on neuroscience in different academic laboratories based in Pasteur Institute (Paris), Marseille and Edinburgh. She continued on as a Medical Writer in MediBridge, a service company for pharmaceutical industries. She joined MedDay in 2014 where she is managing preclinical R&D activities. As Project Leader, she is actively participating in the preparation of regulatory dossiers.